Cassava Sciences: Summary

Cassava Sciences

Biopharmaceutical, Neuroscience, Clinical Research, Neurodegenerative Diseases

Cassava Sciences aims to revolutionize the detection and treatment of Alzheimer's disease, making it as simple as a blood test.

Cassava Sciences is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for Alzheimer's disease. The company focuses on translating novel scientific insights into new medicines to address neurodegenerative conditions.

Focus on neuroscience and neurodegenerative conditions; Development of first-in-class medicines; Collaboration with academic and medical advisors; Support from the National Institutes of Health (NIH)

The service is most valuable for researchers, healthcare professionals, and patients seeking innovative solutions for Alzheimer's disease.

Strong backing from NIH for research funding; Focus on first-in-class therapies; Collaboration with leading academics and medical experts

Cassava Sciences has a clear mission to tackle Alzheimer's disease, a strong research foundation, and a collaborative approach that enhances its development capabilities.

Cassava Sciences positions itself as a leader in the biopharmaceutical industry focused on neuroscience, particularly in the urgent area of Alzheimer's disease.

The target users include investors, healthcare professionals, researchers in neuroscience, and families affected by Alzheimer's disease.

The brand is identified as a pioneering biopharmaceutical company dedicated to addressing one of the most pressing health challenges of our time.

Sign Up for Alerts

The company is unique in its commitment to developing novel approaches for Alzheimer's treatment and diagnosis, emphasizing collaboration and innovative research.

Our mission is to detect and treat Alzheimer’s disease.

• Alzheimer's disease

• biopharmaceutical

• neuroscience

• clinical trials

Innovative, urgent, collaborative

1998-01-01

• Remi Barbier